It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and regulatory updates were in focus. Recap of the Week’s ...
Zacks.com on MSN7h
Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDAIt was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...
Hosted on MSN20h
FDA removes clinical hold on Entrada’s Duchenne therapyEntrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...
Thank you, and welcome to the Global Industrial fourth quarter 2024 earnings call. Today's call will include formal remarks from Richard Leeds, Executive Chairman; Anesa Chaibi, Chief Executive ...
Total reported sales of $1.6 billion, down 10% versus the prior year period on a reported basis. The decrease in reported ...
Full Year Results Earnings Conference Call February 26, 2025 3:30 AM ETCompany ParticipantsLiam Hennigan – Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback